机器人辅助与腹腔镜减重手术的30天严重不良事件:全国MBSAQIP分析
基于MBSAQIP数据库2020至2024年949,507例成人微创减重手术的回顾性队列研究,比较机器人辅助腹腔镜(291,483例)与常规腹腔镜(658,024例)。调整混杂后,机器人辅助与各术式30天严重不良事件风险升高相关,校正超额风险从每1000例袖状胃切除术2.4例事件至每1000例十二指肠转流或单吻合口十二指肠回肠旁路联合袖状胃切除术15.2例事件;死亡率罕见且两组相似。结论认为机器人辅助减重手术未改善30天患者安全。
要点
- 机器人辅助减重手术与30天严重不良事件校正超额风险升高相关。
- 超额风险从袖状胃切除术2.4/1000例至十二指肠转流或单吻合口旁路15.2/1000例。
- 差异主要分布于再入院、再手术和再干预,死亡率罕见且两平台相似。
核心结论
- 在全国MBSAQIP队列中,机器人辅助减重手术未改善30天患者安全,并与小幅校正超额严重不良事件风险相关。
- 在将短期安全获益归因于机器人 adoption 之前,需要纳入外科医生和中心层面数据的前瞻性研究。
研究设计与样本
- 回顾性队列研究,纳入2020至2024年MBSAQIP认证美国中心949,507例接受微创袖状胃切除术、Roux-en-Y胃旁路术或十二指肠转流/单吻合口十二指肠回肠旁路联合袖状胃切除术的成人。
- 机器人辅助腹腔镜291,483例与常规腹腔镜658,024例比较,主要终点为30天复合严重不良事件。
- 采用解剖分层、考虑中转的多变量logistic回归(稳健标准误和边际标准化)估计校正绝对风险差。
主要发现
- 调整人口学、合并症、手术年份和中转状态后,机器人辅助与各术式和手术背景下30天严重不良事件风险升高相关。
- 校正超额风险从每1000例原发性袖状胃切除术2.4例事件(95% CI 1.5至3.4)至每1000例原发性十二指肠转流或单吻合口十二指肠回肠旁路联合袖状胃切除术15.2例事件(95% CI 5.3至25.1)。
- 袖状胃切除术和Roux-en-Y胃旁路术中,中转手术的超额风险高于原发手术。
- 成分分析显示差异分布于多种事件类型,主要为再入院、再手术和再干预;死亡率罕见且两平台相似。
- 校正超额风险随时间衰减,但平台与年份交互作用无统计学意义(p=0.20)。
临床怎么用
- 在已标准化的低并发症减重手术中,不应默认机器人辅助能改善短期安全。
- 评估机器人平台时应关注再入院、再手术和再干预等具体事件类型。
局限性
- 回顾性设计,未纳入外科医生和中心层面数据。
- 平台与年份交互作用无统计学意义(p=0.20),随时间衰减的结论需谨慎解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Robotic platforms are widely adopted in bariatric surgery, but whether they improve short-term safety in already standardized, low-morbidity operations remains uncertain. STUDY DESIGN: We performed a retrospective cohort study of 949,507 adults undergoing minimally invasive sleeve gastrectomy, Roux-en-Y gastric bypass, or duodenal switch or single-anastomosis duodenoileal bypass with sleeve gastrectomy at MBSAQIP-accredited US centers from 2020 to 2024. Robotic-assisted laparoscopy (291,483) was compared with conventional laparoscopy (658,024). The primary endpoint was 30-day composite serious adverse events. Anatomy-stratified, conversion-aware multivariable logistic regression with robust SEs and marginal standardization estimated adjusted absolute risk differences. RESULTS: After adjustment for patient demographics, comorbidities, operative year, and conversion status, robotic assistance was associated with higher 30-day serious adverse event risk across procedure types and operative contexts. Adjusted excess risk ranged from 2.4 events per 1,000 primary sleeve gastrectomy cases (95% CI 1.5 to 3.4) to 15.2 events per 1,000 primary duodenal switch or single-anastomosis duodenoileal bypass with sleeve gastrectomy cases (95% CI 5.3 to 25.1). Excess risk was higher in conversion than primary operations for sleeve gastrectomy and Roux-en-Y gastric bypass. Component analysis showed differences distributed across multiple event types, predominantly readmission, reoperation, and reintervention; mortality was rare and similar between platforms. Adjusted excess risk attenuated over time, but the platform-by-year interaction was NS (p = 0.20). CONCLUSIONS: In this national MBSAQIP cohort, robotic-assisted bariatric surgery was not associated with improved 30-day patient safety and was associated with small adjusted excess serious adverse event risk. Prospective studies incorporating surgeon- and center-level data are needed before short-term safety benefit is attributed to robotic adoption.
引用
- Dallal RM, Eid GM, Neff M, et al. Robotic-Assisted vs Laparoscopic Bariatric Surgery and 30-Day Serious Adverse Events: A National MBSAQIP Analysis. J Am Coll Surg. 2026. PMID: 42339836. doi:10.1097/XCS.0000000000002049
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。